Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorPeking Union Medical College Hospital

About this trial

An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age <= 18 years old

Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity)

Diagnosed and Treated in China

Disqualifiers

Disagreement of involving in this study by the patient or his/her family.

Trial population

Chinese children with pediatric rheumatic and immunologic diseases enrolled from CAPRID centers.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Number of Enrolled Patients

Total number of patients with pediatric rheumatic and immunologic diseases enrolled in the registry

Time frame
up to 10 years

Secondary outcomes

1

Physician Global Assessment

Visual Analog Score measurement of disease activity by physicians. The minimum value is 0 and the maximum is 10.

Time frame
up to 10 years
2

Patient or Parent Global Assessment

Visual Analog Score measurement of disease activity by patient's parent or patient him or her self (above 8 years old). The minimum value is 0 and the maximum is 10.

Time frame
up to 10 years
3

Proportion of Participants with Clinically Inactive Disease

Defined by normal disease activity indexes (if available) and normal inflammatory markers (erythrocyte sedimentation rate and C-reactive protein). Disease activity indexes include Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) for systemic lupus erythematosus; Juvenile Arthritis Disease Activity Score (JADAS)-27 for juvenile idiopathic arthritis, Pediatric Vasculitis Activity Score (PVAS) for vasculitis; Manual Muscle Testing(MMT)8, Childhood Myositis Assessment Scale (CMAS) for juvenile dermatomyositis, Sjögren's syndrome disease activity index (ESSDAI) for Sjögren's syndrome, Modified Rodnan Skin Score for scleroderma.

Time frame
up to 10 years
4

Childhood Health Assessment Questionnaire (CHAQ)

Composite measure of functional disability, score from 0 (no disability) to 3 (severe disability)

Time frame
up to 10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Peking Union Medical College Hospital

Lead sponsor

Children's Hospital of Chongqing Medical University

Collaborator

Central South University

Collaborator

Beijing Children's Hospital

Collaborator

Shenzhen Children's Hospital

Collaborator

Children's Hospital of Nanjing Medical University

Collaborator

The University of Hong Kong

Collaborator

Zhejiang University

Collaborator

Peking University Third Hospital

Collaborator